By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DURECT Corporation 

2 Results Way

Cupertino  California  95014  U.S.A.
Phone: 408-777-1417 Fax: 408-777-3577



Company News
DURECT (DRRX) Announces FDA Advisory Committee Meeting For REMOXY 5/19/2016 10:51:53 AM
DURECT (DRRX) Announces New REMOXY Data Being Presented At American Pain Society Meeting 5/11/2016 8:55:32 AM
DURECT (DRRX) Announces First Quarter 2016 Financial Results And Update Of Programs 5/6/2016 6:48:55 AM
DURECT (DRRX) Announces Closing Of Public Offering Of Common Stock 4/29/2016 11:44:37 AM
DURECT (DRRX) Invites You To Join Its First Quarter 2016 Earnings Conference Call 4/29/2016 6:50:53 AM
DURECT (DRRX) Announces Pricing Of Public Offering Of Common Stock 4/26/2016 7:42:06 AM
DURECT (DRRX) Announces Proposed Public Offering Of Common Stock 4/26/2016 6:34:33 AM
DURECT (DRRX) Announces FDA Acceptance Of REMOXY NDA, PDUFA Date Of September 25, 2016 4/13/2016 5:58:24 AM
DURECT (DRRX) Falls Premarket After the FDA Asks for PERSIST Trial Amendments 4/8/2016 7:21:17 AM
DURECT Corporation (DRRX) Announces Resubmission Of REMOXY New Drug Application To The FDA 3/29/2016 9:35:37 AM